Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 12 | $1.16 | $1.58 | $1.38 |
| Q2 2026 | 13 | $1.79 | $3.13 | $2.20 |
| Q3 2026 | 10 | -$3.37 | -$1.98 | -$2.83 |
| Q4 2026 | 11 | $1.60 | $2.18 | $1.95 |
| Q1 2027 | 4 | $1.66 | $1.76 | $1.70 |
| Q2 2027 | 4 | $2.02 | $2.15 | $2.08 |
| Q3 2027 | 7 | $2.11 | $2.25 | $2.17 |
| Q4 2027 | 4 | $2.33 | $2.48 | $2.39 |
| Q1 2028 | 5 | $1.97 | $2.09 | $2.02 |
| Q2 2028 | 6 | $2.48 | $2.63 | $2.54 |
| Q3 2028 | 9 | $1.94 | $2.06 | $1.99 |
| Q4 2028 | 5 | $1.92 | $2.04 | $1.97 |
Incyte Corp. last posted its earnings results on Tuesday, July 28th, 2026. The company reported $3.09 earnings per share for the quarter, topping analysts' consensus estimates of $2.15 by $0.94. The company had revenue of 1.67 B for the quarter and had revenue of 5.14 B for the year. Incyte Corp. has generated $7 earnings per share over the last year ($6.41 diluted earnings per share) and currently has a price-to-earnings ratio of 15.72. Incyte Corp. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/28/2026 | Q2 2026 | $2.15 | $2.92 | 0.77 | $1.50 B | $1.67 B |
| 04/28/2026 | Q1 2026 | $1.34 | $1.52 | 0.18 | $1.22 B | $1.27 B |
| 02/10/2026 | Q4 2025 | $1.90 | $1.52 | -0.38 | $1.35 B | $1.51 B |
| 10/28/2025 | Q3 2025 | $1.66 | $2.17 | 0.51 | $1.25 B | $1.37 B |
| 07/29/2025 | Q2 2025 | $1.39 | $2.09 | 0.7 | $1.15 B | $1.22 B |
| 04/29/2025 | Q1 2025 | $1.01 | $0.82 | -0.19 | $985.11 M | $1.05 B |
| 02/10/2025 | Q4 2024 | $1.57 | $1.04 | -0.53 | $1.14 B | $1.18 B |
| 10/29/2024 | Q3 2024 | $1.12 | $0.55 | -0.57 | $1.08 B | $1.14 B |
| 07/30/2024 | Q2 2024 | $0.78 | -$2.04 | -2.82 | $1.01 B | $1.04 B |
| 04/30/2024 | Q1 2024 | $0.84 | $0.76 | -0.08 | $921.89 M | $880.89 M |
| 02/16/2024 | Q4 2023 | N/A | $0.90 | N/A | $1.00 B | $1.01 B |
| 10/31/2023 | Q3 2023 | $1.09 | $0.76 | -0.33 | $963.63 M | $919.03 M |
| 08/01/2023 | Q2 2023 | $0.83 | $0.91 | 0.08 | $909.68 M | $954.61 M |
| 05/02/2023 | Q1 2023 | $0.56 | $0.10 | -0.46 | $859.17 M | $808.67 M |
| 02/07/2023 | Q4 2022 | $0.58 | $0.13 | -0.45 | $878.25 M | $926.70 M |
| 11/01/2022 | Q3 2022 | $0.72 | $0.51 | -0.21 | $842.66 M | $823.30 M |
| 08/02/2022 | Q2 2022 | $0.79 | $0.73 | -0.06 | $818.49 M | $911.40 M |
| 05/03/2022 | Q1 2022 | $0.57 | $0.17 | -0.4 | $749.98 M | $733.24 M |
| 02/08/2022 | Q4 2021 | $0.84 | $2.55 | 1.71 | $812.44 M | $862.85 M |
| 11/02/2021 | Q3 2021 | $0.76 | $0.82 | 0.06 | $746.09 M | $812.99 M |
In the previous quarter, Incyte Corp. (:INCY) reported $3.09 earnings per share (EPS) to beat the analysts' consensus estimate of $2.15 by $0.94.
The conference call for Incyte Corp.'s latest earnings report can be listened to online.
The conference call transcript for Incyte Corp.'s latest earnings report can be read online.
Incyte Corp. (:INCY) has a recorded annual revenue of $5.14 B.
Incyte Corp. (:INCY) has a recorded net income of $1.29 B.Incyte Corp. has generated $6.59 earnings per share over the last four quarters.
Incyte Corp. (:INCY) has a price-to-earnings ratio of 15.72 and price/earnings-to-growth ratio is 0.19.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED